Urine sodium excretion is related to extracellular water volume but not to blood pressure in 510 normotensive and never-treated hypertensive subjects von Taurio, Jyrki, Koskela, Jenni, Sinisalo, Marjatta, Tikkakoski, Antti, Niemelä, Onni, Hämäläinen, Mari, Moilanen, Eeva, Choudhary, Manoj Kumar, Mustonen, Jukka, Nevalainen, Pasi, Pörsti, Ilkka

Volltext

The characteristics of elevated blood pressure in abdominal obesity correspond to primary hypertension: a cross-sectional study von Taurio, Jyrki, Hautaniemi, Elina J, Koskela, Jenni K, Eräranta, Arttu, Hämäläinen, Mari, Tikkakoski, Antti, Kettunen, Jarkko A, Kähönen, Mika, Niemelä, Onni, Moilanen, Eeva, Mustonen, Jukka, Pörsti, Ilkka

Volltext

Prospective, randomized, double-blinded, placebo-controlled study on safety and tolerability of the krill powder product in overweight subjects with moderately elevated blood press... von Sarkkinen, Essi S, Savolainen, Markku J, Taurio, Jyrki, Marvola, Tuuli, Bruheim, Inge

Volltext

Team-based “Get-a-Grip” lifestyle management programme in the treatment of obesity von Taurio, Jyrki, Järvinen, Jorma, Hautaniemi, Elina J., Eräranta, Arttu, Viitala, Jani, Nordhausen, Klaus, Kaukinen, Katri, Mustonen, Jukka, Pörsti, Ilkka H.

Volltext

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial von Bellet, Marc, Bakris, George L, Flack, John M, Wang, Ji-Guang, Schlaich, Markus, Katz, Ivor, Ajani, Andrew, Colquhoun, David, Mooney, John, De Backer, Tine, Persu, Alexandre, Chaumont, Martin, Vanassche, Thomas, Pliamm, Lew, Merali, Fatima, Dresser, George, Vallee, Michel, Jolly, Shivinder, Wang, Jiguang, Mu, Jianjun, Yu, Jing, Yuan, Hong, Zhang, Xin, Xie, Jianhong, Lin, Ling, Soucek, Miroslav, Widimsky, Jiri, Cifkova, Renata, Vaclavik, Jan, Ormezzano, Olivier, Azizi, Michel, Courand, Pierre-Yves, Ott, Christian, Kyfnidis, Konstantinos, Manolis, Athanasios, Patsilinakos, Sotirios, Zebekakis, Pantelis, Karavidas, Apostolos, Denes, Pall, Sukholutsky, Ivetta, Yosefy, Chaim, Kenis, Irina, Maria Lorenza, Muiesan, Taddei, Stefano, Lee, Hae-Young, Raugaliene, Rasa, Kavaliauskiene, Roma, Kroon, Abraham, Januszewicz, Andrzej, Tykarski, Andrzej, Chrostowska, Marzena, Krekora, Jan, Kania, Grzegorz, Podziewski, Maciej, Wilkolaski, Andrzej, Janik-Palazzolo, Marzena, Rewerska, Barbara, Konradi, Aleksandra, Nikolaev, Konstantin, Gorbunov, Vladimir, Obrezan, Andrey, Kuzin, Anatoly, Martínez García, Fernando, Redon, Josep, Oliveras, Anna, Bazylevych, Andriy, Karpenko, Oleksandr, Asanov, Ervin, Gupta, Pankaj, Webb, David, MacLeod, Mary, Peace, Aaron, Arora, Samir, Degarmo, Ronald, Guillen, Mario, Karns, Adam, Paliwal, Yogesh, Butcher, Michael Bain, Calhoun, David, Goldman, Jesse M., Rashidi, Arash, Haley, William, Lang, Brian, Khanna, Dinesh, Park, Jean, Luna, Blanca, Mussaji, Murtaza, McGinty, John, McGrew, Frank, Bolster, Eric, Kalirao, Paramjit, Dabel, Pascal, Calhoun, Wesley, Gouge, Steven, Warren, Mark, Lawrence, Mary Katherine, El-Shahawy, Mohamed, Mercado, Carlos, Kumar, Jayant, Velasquez-Mieyer, Pedro

Volltext

Aging Fabry disease patients von Kantola, Ilkka, Hietaharju, Aki, Kuusisto, Johanna, Kylmälä, Minna M., Effati, Paivi Pietila, Taurio, Jyrki, Valtola, Kati, Yliaska, Iina, Saarinen, Jukka

Volltext

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study von Dandona, Paresh, Mathieu, Chantal, Phillip, Moshe, Hansen, Lars, Tschöpe, Diethelm, Thorén, Fredrik, Xu, John, Langkilde, Anna Maria

Volltext

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised cont... von Mathieu, Chantal, Phillip, Moshe, Griffen, Steven C, Tschöpe, Diethelm, Thorén, Fredrik, Langkilde, Anna Maria, Proietto, Joseph, Stranks, Stephen, Chen, Roger, Pape, Alexia, Forbes, Mark, Morbey, Claire, Schnack, Christoph, Fliesser-Goerzer, Evelyn, Hoelzl, Bertram, Prager, Rudolf, Vercammen, Chris, Mathieu, Chantal, Ruige, Johannes, Woo, Vincent, St-Pierre, Bruno, Hramiak, Irene, Krarup Hansen, Troels, Gram, Jeppe, Saltevo, Juha, Taurio, Jyrki, Nieminen, Sakari, Pietilainen, Kirsi, Hadjadj, Samy, Cariou, Bertrand, Borot, Sophie, Tschoepe, Diethelm, Marck, Cornelia, Horacek, Thomas, Rose, Ludger, Goebel, Rolf, Kerenyi, Zsuzsanna, Oroszlan, Tamas, Konyves, Laszlo, Phillip, Moshe, Mosenzon, Ofri, Shehadeh, Naim, Adawi, Faiad, Wainstein, Julio, Dotta, Francesco, Genovese, Stefano, Di Bartolo, Paolo, Mannucci, Edoardo, Lapolla, Annunziata, Esteban, Alberto, Ruiz, Bazzoni, Ramirez, Guillermo Mondragon, Pelayo Orozco, Emilia, Medina Pech, Carlos, Sauque Reyna, Leobardo, Llamas Esperon, Guillermo, Nevarez Ruiz, Luis Alejandro, Vidrio Velazquez, Maricela, Garcia-Hernandez, Pedro Alberto, Araujo-Silva, Roberto, Villeda - Espinosa, Efrain, Popescu, Daniela, Constantin, Ciprian, Popa, Bogdan, Timar, Romulus, Pintilei, Ella, Gimenez, Margarita, Mezquita, Pedro, Eriksson, Jan, Londahl, Magnus, Eliasson, Bjorn, Gunstone, Anthony, Heller, Simon, Darzy, Ken, Mansell, Peter, Davies, Melanie, Courtney, Hamish, Turner, Wayne, Blagden, Mark, McCrimmon, Rory, Lane, Wendy, Lucas, Kathryn, White, Judith, Jantzi, Curtis, Ervin, William, Cleland, Alan, Fink, Raymond, Rodbard, Helena, Nakhle, Samer, Bays, Harold, Kane, Laurie, Ipp, Eli, Garg, Satish, Bhargava, Anuj, Rosenstock, Julio, Young, Laura, Aroda, Vanita, Pettus, Jeremy, Liljenquist, David, Dandona, Paresh

Volltext

Enzyme replacement therapy with renin-angiotensin system inhibition prevents kidney function decrease in most Finnish Fabry disease patients treated for 5 or 10 years von Kantola, Ilkka M., Helioe, Tiina Maria, Hietaharju, Aki Juhani, Kantola, Taru, Kuusisto, Johanna, Kylmälä, Minna M., Lapatto, Risto, Effati, Paivi Pietila, Saarinen, Jukka T., Taurio, Jyrki, Vaarpu, Mary, Valtola, Kati, Walls, Susanne, Yliaska, Iina

Volltext

Start age of enzyme replacement therapy (ERT) did not effect ECG parameters in Fabry disease patients (FD) treated by ERT for 5 years von Kantola, Ilkka, Annala, Antti-Pekka, Hietaharju, Aki, Helioe, Tiina M., Kantola, Taru-Tuuli, Kuusisto, Johanna, Effati, Paivi Pietila, Saarinen, Jukka, Taurio, Jyrki, Walls, Susanne, Valtola, Kati, Yliaska, Iina

Volltext

Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial von Solomon, Scott D, Rizkala, Adel R, Lefkowitz, Martin P, Shi, Victor C, Gong, JianJian, Anavekar, Nagesh, Anker, Stefan D, Arango, Juan L, Arenas, Jose L, Atar, Dan, Ben-Gal, Turia, Boytsov, Sergey A, Chen, Chen-Huan, Chopra, Vijay K, Cleland, John, Comin-Colet, Josep, Duengen, Hans-Dirk, Echeverría Correa, Luis E, Filippatos, Gerasimos, Flammer, Andreas J, Galinier, Michel, Godoy, Armando, Goncalvesova, Eva, Janssens, Stefan, Katova, Tzvetana, Køber, Lars, Lelonek, Małgorzata, Linssen, Gerard, Lund, Lars H, O'Meara, Eileen, Merkely, Béla, Milicic, Davor, Oh, Byung-Hee, Perrone, Sergio V, Ranjith, Naresh, Saito, Yoshihiko, Saraiva, Jose F, Shah, Sanjiv, Seferovic, Petar M, Senni, Michele, Sibulo, Jr, Antonio S, Sim, David, Sweitzer, Nancy K, Taurio, Jyrki, Vinereanu, Dragos, Vrtovec, Bojan, Widimský, Jr, Jiří, Yilmaz, Mehmet B, Zhou, Jingmin, Zweiker, Robert, Anand, Inder S, Ge, Junbo, Lam, Carolyn S P, Maggioni, Aldo P, Martinez, Felipe, Packer, Milton, Pfeffer, Marc A, Pieske, Burkert, Redfield, Margaret M, Rouleau, Jean L, Van Veldhuisen, Dirk J, Zannad, Faiez, Zile, Michael R, McMurray, John J V

Volltext

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study von Ray, Kausik K, Aguiar, Carlos, Arca, Marcello, Connolly, Derek L, Eriksson, Mats, Ferrières, Jean, Laufs, Ulrich, Mostaza, Jose M, Nanchen, David, Bardet, Aurélie, Lamparter, Mathias, Chhabra, Richa, Soronen, Jarkko, Rietzschel, Ernst, Strandberg, Timo, Toplak, Hermann, Visseren, Frank L J, Catapano, Alberico L

Volltext

PQ interval, QRS duration and QTc interval increased in Fabry disease patients treated by enzyme replacement therapy both for 10 and 15 years von Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Helio, Tiina, Hietaharju, Aki, Kantola, Taru, Kananen, Kristiina, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Paivi, Rainto, Miia, Saarinen, Jukka, Sandini, Lorenzo, Taurio, Jyrki, Walls, Susanne, Valtola, Kati, Yliaska, Iina

Volltext

Deterioration in ECG parameters in Fabry females and males treated by enzyme replacement therapy either for 5 or 10 years von Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Helio, Tiina, Hietaharju, Aki, Kantola, Taru, Kananen, Kristiina, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Paivi, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Ukkola, Olavi, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Volltext

Enzyme replacement therapy together with renin-angiotensin system inhibition seems to prevent kidney function decrease in most Finnish Fabry patients treated either for 5 or 10 yea... von Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Heliö, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Päivi, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Ukkola, Olavi, Valtola, Kati, Walls, Susanne, Yliaska, Iina

Volltext

Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia von Sinisalo, Marjatta, Vilpo, Juhani, Itälä, Maija, Väkeväinen, Merja, Taurio, Jyrki, Aittoniemi, Janne

Volltext

PQ-interval and QRS duration increased in Fabry patients treated by enzyme replacement therapy for 12 years von Kantola, Ilkka, Annala, Antti-Pekka, Helio, Tiina, Hietaharju, Aki, Kantola, Taru, Kananen, Kristiina, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Paivi, Rainto, Miia, Saarinen, Jukka, Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Volltext

Control of vascular tone in isolated mesenteric arterial segments from hypertensive patients von Hutri‐Kähönen, Nina, Kähönen, Mika, Wu, Xiumin, Sand, Juhani, Nordback, Isto, Taurio, Jyrki, Pörsti, Ilkka

Volltext

Enzyme replacement therapy carries for 4-7 years in Fabry disease thereafter quality of life decreases von Kantola, I. Ilkka, Annala, Antti-Pekka, Helio, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kuusisto, Johanna, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Volltext

Enzyme replacement therapy carries for 4-7years in Fabry disease thereafter quality of life decreases von Kantola, I. Ilkka, Annala, Antti-Pekka, Helio, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kuusisto, Johanna, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Volltext